Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/02/20 → 30/06/25 |
Funding
- National Institute for Health Research: £62,801.83
- National Institute for Health Research: £1,565,689.47
What is the clinical effectiveness and cost-effectiveness of nebulised saline in patients with chronic obstructive pulmonary disease (MucAct COPD Trial)?
- Lewis, Steff (Co-investigator)
- Sheikh, Aziz (Co-investigator)
- Stoddart, Andrew (Co-investigator)